(Q37554785)

21 August 2017

Scalp psoriasis: European consensus on grading and treatment algorithm (English)

1 reference

21 August 2017

4

L Puig

1 reference

21 August 2017

Jp Ortonne

1

1 reference

21 August 2017

S Chimenti

2

1 reference

21 August 2017

T Luger

3

1 reference

21 August 2017

F Reid

5

1 reference

21 August 2017

R M Trüeb

6

1 reference

21 August 2017

15 July 2009

1 reference

Journal of the European Academy of Dermatology and Venereology

21 August 2017

1 reference

21 August 2017

23

1 reference

21 August 2017

12

1 reference

21 August 2017

1435-1444

1 reference

Psoriasis of the scalp. Diagnosis and management

21 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Topical preparations for the treatment of psoriasis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Differing degrees of coal-tar shampoo-induced mutagenesis in the Salmonella/liver test system in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Human hair follicle benzo[a]pyrene and benzo[a]pyrene 7,8-diol metabolism: effect of exposure to a coal tar-containing shampoo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Response of scalp psoriasis to oral ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture, and in mouse skin and lung following topical application of coal-tar and juniper tar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

Scalpdex: a quality-of-life instrument for scalp dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03372.X

10.1111/J.1468-3083.2009.03372.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference